Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis

BACKGROUND: Intravenous thrombolysis using recombinant tissue plasminogen activator remains the mainstay treatment of acute ischemic stroke (AIS), although endovascular treatment is becoming standard of care in case of large vessel occlusions (LVO). To quantify the thrombus burden in LVO, a semiquan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Szegedi, István, Orbán-Kálmándi, Rita, Nagy, Attila, Sarkady, Ferenc, Vasas, Nikolett, Sik, Máté, Lánczi, Levente István, Berényi, Ervin, Oláh, László, Crișan, Alexandra, Csiba, László, Bagoly, Zsuzsa
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8263307/
https://ncbi.nlm.nih.gov/pubmed/34234378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0254253
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados